<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04922034</url>
  </required_header>
  <id_info>
    <org_study_id>49RC21_0178</org_study_id>
    <nct_id>NCT04922034</nct_id>
  </id_info>
  <brief_title>Outcome of Patients After a Negative Oral Challenge to Amoxicillin</brief_title>
  <acronym>REINAD</acronym>
  <official_title>Study of Patient's Outcomes After a Negative Reintroduction Test for Amoxicillin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the outcome of patients who had a negative oral challenge to&#xD;
      Amoxicillin&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, single-center, non-interventional study of patients with negative&#xD;
      Amoxicillin oral challenge performed at Angers University Hospital between 2017 and 2019.&#xD;
&#xD;
      An information letter indicating the purpose of the study is sent to eligible patients. If&#xD;
      they do not object, patients are contacted by telephone to answer the questionnaire. This&#xD;
      questionnaire concerns the reintroduction of penicillins at home after the challenge.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 31, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Resumption of Amoxicillin after a negative oral challenge to Amoxicillin</measure>
    <time_frame>Oral challenge test oxxuring between 2017 and 2019, and follow-up until the day of the call</time_frame>
    <description>The main objective is to know if patients who had a negative test for reintroduction of Amoxicillin, have resumed this molecule afterwards.</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Negative Challenge to Amoxicillin</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin</intervention_name>
    <description>Outcome of patients with negative oral challenge to amoxicillin</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This is a prospective, single-center, non-interventionnel study of patients with a negative&#xD;
        oral challenge to Amoxicillin at Angers University Hospital between 2017 and 2019.&#xD;
&#xD;
        An information letter indicating the purpose of the study is sent to eligible patients. If&#xD;
        they do not object, patients are contacted by telephone one month after the information&#xD;
        letter is sent, to answer the questionnaire. This questionnaire, filled in during the&#xD;
        telephone interview, concerns the resumption or not of penicillins since the reintroduction&#xD;
        test.&#xD;
&#xD;
        This study concerns all patients, agreeing to participate in this study, who had a negative&#xD;
        challenge test to Amoxicillin at the CHU of Angers from 2017 to 2019.&#xD;
&#xD;
        The potential inclusion is approximately 200 individuals.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients whith a negative challenge to Amoxicillin in the Allergology Department of&#xD;
             the CHU of Angers between 2017 and 2019.&#xD;
&#xD;
          -  Major patients.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Poor comprehension of the French language or cognitive disorders affecting the&#xD;
             reliability of the questionnaire&#xD;
&#xD;
          -  Person objecting to participate in this research and to the processing of their&#xD;
             medical data&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Martine Morisset, MD</last_name>
    <phone>(33) 02 41 35 35 51</phone>
    <email>Martine.Morisset@chu-angers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hortense Herv√© Marraud de Sigalony</last_name>
    <phone>(33) 02 41 35 35 51</phone>
    <email>HortenseHerveDeSigalony@chu-angers.fr</email>
  </overall_contact_backup>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 4, 2021</study_first_submitted>
  <study_first_submitted_qc>June 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 10, 2021</study_first_posted>
  <last_update_submitted>June 10, 2021</last_update_submitted>
  <last_update_submitted_qc>June 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>penicillins</keyword>
  <keyword>reintroduction</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amoxicillin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

